Lonza upgrades clinical manufacturing services at Bend site to include bottling and labeling capabilities
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
Revolutionary technology will further boost OneSource’s scientific services offerings
The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances
Emraclidine, a potential best-in-class, next-generation antipsychotic, is in trials designed to be registration enabling for schizophrenia
Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore
The drug will be marketed in different strengths of 150 mg and 440 mg and used in the treatment of patients with HER2
GSK and Flagship to jointly fund up to $150 million upfront
Report highlights significant improvements in adolescent well-being in India
Campaign launched to spread awareness regarding dengue prevention and control
Subscribe To Our Newsletter & Stay Updated